Kidney diseases encompass a range of conditions affecting the function and structure of the kidneys, vital organs responsible for filtering waste and excess fluids from the blood, regulating electrolyte balance, and producing hormones that control blood pressure and red blood cell production.
The main types of treatments for kidney disease include medication, dialysis, surgery, and others. Medication involves the use of drugs or pharmaceutical substances to treat, manage, or prevent various medical conditions associated with kidney diseases. These treatments are indicated for conditions such as acute kidney injury, chronic kidney disease, end-stage renal disease, and others, administered through oral and parenteral routes of administration. Various end-users, including hospitals and diagnostic laboratories, utilize these treatments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The kidney disease research report is one of a series of new reports from The Business Research Company that provides kidney disease market statistics, including the kidney disease industry's global market size, regional shares, competitors with a kidney disease market share, detailed kidney disease market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney disease industry. This kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The kidney disease market size has grown strongly in recent years. It will grow from $107.29 billion in 2024 to $114.39 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising chronic health conditions, aging population, genetic predisposition, medical research and education, environmental factors.
The kidney disease market size is expected to see strong growth in the next few years. It will grow to $148.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to global infectious disease management, precision medicine approaches, diabetes and obesity epidemic, healthcare policy changes, increased awareness and screening. Major trends in the forecast period include telemedicine for kidney care, focus on preventive nephrology, rise in home-based dialysis, regenerative therapies development, dietary modifications and nutrition.
The forecast of 6.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S.by increasing the cost of renal anemia medications and glomerular filtration rate testing reagents sourced from Denmark and France, thereby delaying chronic kidney disease management and elevating nephrology care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in the incidence of kidney diseases is expected to drive the growth of the kidney disease market. Kidney diseases encompass a range of conditions affecting the structure and function of the kidneys. Medications for kidney disorders play a crucial role in managing symptoms, reducing protein loss, and slowing the progression of kidney damage, ultimately preventing complications. In June 2023, Kidney Research UK reported that an estimated 7.19 million people in the UK were affected by chronic kidney disease, representing over 10% of the population and projected to rise to 7.61 million people by 2033. Therefore, the heightened incidence of kidney diseases serves as a significant driver propelling the growth of the kidney disease market.
The increasing prevalence of high blood pressure and diabetes is expected to contribute significantly to the growth of the kidney disease market. High blood pressure, characterized by elevated blood force against arterial walls, and diabetes, a metabolic disorder leading to high blood glucose levels, are major contributors to kidney diseases. The sustained damage caused by high blood pressure and diabetes to the small blood vessels in the kidneys can result in kidney damage, impacting their ability to effectively filter waste and excess fluids from the blood. According to the National Diabetes Statistics Report, approximately 38.4 million people in the United States will have diabetes in 2023, constituting 11.6% of the population. Therefore, the increasing prevalence of high blood pressure and diabetes is a driving force behind the growth of the kidney disease market.
An emerging trend gaining traction in the kidney disease market is the integration of AI-driven tools. Companies in the kidney disease market are adopting new technologies, particularly AI solutions, to enhance patient outcomes and maintain their competitive edge. For instance, in November 2022, Carenostics, a US-based healthcare startup specializing in AI solutions, has introduced a product designed to analyze electronic health record (EHR) data for the early identification of chronic kidney disease (CKD). By seamlessly integrating AI-powered clinical decision support models into healthcare providers' EHR systems, Carenostics empowers clinicians to accurately identify high-risk patients with chronic diseases, facilitating proactive measures for improved patient outcomes.
Major companies in the kidney disease market are adopting a strategic partnership approach to enhance patient care, drive innovation, and expedite the commercialization of therapies. For instance, in June 2023, Southern California Kidney Consultants Inc., a US-based medical practices company, has partnered with Strive Health, a US-based healthcare company, to improve kidney disease treatment and care. The partnership involves 21 providers primarily based in Orange County, serving 5,000 patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.8 billion. This strategic move enables AstraZeneca to bolster its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat, an aldosterone synthase inhibitor (ASI), is designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.
Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.
North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The kidney disease market consists of revenues earned by providing services such as hemodialysis, peritoneal dialysis, and kidney transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney disease also includes sales of drugs such as galafold, sibnayal, tarpeyo, and cystadrops. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Kidney Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on kidney disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for kidney disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The kidney disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment: Medication; Dialysis; Surgery; Other Treatments
- 2) By Indication: Acute Kidney Injury; Chronic Kidney Disease; End-Stage Renal Disease; Other Indication
- 3) By Route Of Administration: Oral; Parenteral
- 4) By End-User: Hospitals; Diagnostic Laboratories; Other End-Users
- Subsegments:
- 1) By Medication: Antihypertensives; Erythropoiesis-Stimulating Agents (ESAs); Phosphate Binders; Vitamin D Analogs; Immunosuppressants
- 2) By Dialysis: Hemodialysis; Peritoneal Dialysis
- 3) By Surgery: Kidney Transplant; Nephrectomy; Renal Artery Bypass; Ureteral Surgery
- 4) By Other Treatments: Lifestyle And Dietary Modifications; Renal Replacement Therapy; Palliative Care
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Ltd.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi Aventis LLC; Bristol-Myers Squibb Company; AstraZeneca Pharmaceuticals LP; Abbott Laboratories; Fresenius SE & Co. KGaA; GlaxoSmithKline Plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Co Ltd.; Gilead Sciences Inc.; Amgen Inc.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Ltd.; Astellas Pharma Inc.; Vertex Pharmaceuticals Inc.; Otsuka Pharmaceutical Co. Ltd.; Mitsubishi Tanabe Pharma Corporation; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Kyowa Kirin Co. Ltd.; Cipla Inc.; Endo International plc.; Lupin Limited; Kissei Pharmaceutical Co. Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Kidney Disease Market Characteristics
3. Kidney Disease Market Trends And Strategies
4. Kidney Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Kidney Disease Growth Analysis And Strategic Analysis Framework
- 5.1. Global Kidney Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Kidney Disease Market Growth Rate Analysis
- 5.4. Global Kidney Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Kidney Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Kidney Disease Total Addressable Market (TAM)
6. Kidney Disease Market Segmentation
- 6.1. Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medication
- Dialysis
- Surgery
- Other Treatments
- 6.2. Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute Kidney Injury
- Chronic Kidney Disease
- End-Stage Renal Disease
- Other Indication
- 6.3. Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- 6.4. Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Laboratories
- Other End-Users
- 6.5. Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antihypertensives
- Erythropoiesis-Stimulating Agents (ESAs)
- Phosphate Binders
- Vitamin D Analogs
- Immunosuppressants
- 6.6. Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hemodialysis
- Peritoneal Dialysis
- 6.7. Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Kidney Transplant
- Nephrectomy
- Renal Artery Bypass
- Ureteral Surgery
- 6.8. Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lifestyle And Dietary Modifications
- Renal Replacement Therapy
- Palliative Care
7. Kidney Disease Market Regional And Country Analysis
- 7.1. Global Kidney Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Kidney Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Kidney Disease Market
- 8.1. Asia-Pacific Kidney Disease Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Kidney Disease Market
- 9.1. China Kidney Disease Market Overview
- 9.2. China Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Kidney Disease Market
- 10.1. India Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Kidney Disease Market
- 11.1. Japan Kidney Disease Market Overview
- 11.2. Japan Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Kidney Disease Market
- 12.1. Australia Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Kidney Disease Market
- 13.1. Indonesia Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Kidney Disease Market
- 14.1. South Korea Kidney Disease Market Overview
- 14.2. South Korea Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Kidney Disease Market
- 15.1. Western Europe Kidney Disease Market Overview
- 15.2. Western Europe Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Kidney Disease Market
- 16.1. UK Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Kidney Disease Market
- 17.1. Germany Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Kidney Disease Market
- 18.1. France Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Kidney Disease Market
- 19.1. Italy Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Kidney Disease Market
- 20.1. Spain Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Kidney Disease Market
- 21.1. Eastern Europe Kidney Disease Market Overview
- 21.2. Eastern Europe Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Kidney Disease Market
- 22.1. Russia Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Kidney Disease Market
- 23.1. North America Kidney Disease Market Overview
- 23.2. North America Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Kidney Disease Market
- 24.1. USA Kidney Disease Market Overview
- 24.2. USA Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Kidney Disease Market
- 25.1. Canada Kidney Disease Market Overview
- 25.2. Canada Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Kidney Disease Market
- 26.1. South America Kidney Disease Market Overview
- 26.2. South America Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Kidney Disease Market
- 27.1. Brazil Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Kidney Disease Market
- 28.1. Middle East Kidney Disease Market Overview
- 28.2. Middle East Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Kidney Disease Market
- 29.1. Africa Kidney Disease Market Overview
- 29.2. Africa Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Kidney Disease Market Competitive Landscape And Company Profiles
- 30.1. Kidney Disease Market Competitive Landscape
- 30.2. Kidney Disease Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Kidney Disease Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Novartis AG
- 31.3. Sanofi Aventis LLC
- 31.4. Bristol-Myers Squibb Company
- 31.5. AstraZeneca Pharmaceuticals LP
- 31.6. Abbott Laboratories
- 31.7. Fresenius SE & Co. KGaA
- 31.8. GlaxoSmithKline Plc.
- 31.9. Takeda Pharmaceutical Company Limited
- 31.10. Eli Lilly and Co Ltd.
- 31.11. Gilead Sciences Inc.
- 31.12. Amgen Inc.
- 31.13. Boehringer Ingelheim International GmbH
- 31.14. Teva Pharmaceutical Industries Ltd.
- 31.15. Astellas Pharma Inc.
32. Global Kidney Disease Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Kidney Disease Market
34. Recent Developments In The Kidney Disease Market
35. Kidney Disease Market High Potential Countries, Segments and Strategies
- 35.1 Kidney Disease Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Kidney Disease Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Kidney Disease Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
